AbbVie top TV drug ad spender in January as Rinvoq, Skyrizi continue winning streak badams Mon, 02/06/2023 – 09:02 More: AbbVie top TV drug ad spender in January as Rinvoq, Skyrizi continue winning streak Source: fierce
read moreCharity highlights the need to find kidney cancer early and for better guidance among doctors More: Kidney Cancer UK makes NICE plea Source: News
read moreAlvotech will be responsible for supply and Advanz will oversee commercialisation of biosimilar More: Alvotech and Advanz link-up for Xolair drive Source: News
read morePharmaTimes announces the launch of the 2023 event and hopes to see returning contestants from previous years as well as some new faces More: PharmaTimes launches Clinical Researcher of the Year – the Americas 2023 Source: News
read moreAfter AbbVie, Teva walks away from influential trade group PhRMA fkansteiner Fri, 02/03/2023 – 15:53 More: After AbbVie, Teva walks away from influential trade group PhRMA Source: fierce
read moreRegeneron plans summer launch for longer-lasting version of Eylea as it tries to fend off rival Roche kdunleavy Fri, 02/03/2023 – 11:14 More: Regeneron plans summer launch for longer-lasting version of Eylea as it tries to fend off rival Roche
read more© 1994 - 2026 B.M. Pharmaceuticals